Orion Oyj (ORINF)
Orion Oyj operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Espoo, UU, FI. The stock last traded at $82.75, up 0.00% on the session, giving a market capitalisation of $11.66B. On trailing twelve-month figures it carries a trailing P/E of 18.69, a net margin of 28.5%. Its beta of 0.32 implies it has historically moved less than the broad market.
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.
Orion Oyj is most often compared with the following Healthcare names: